FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283659664> ?p ?o ?g. }

• W4283659664 endingPage "432" @default.
• W4283659664 startingPage "426" @default.
• W4283659664 abstract "We previously reported that dual antiplatelet therapy (DAPT) with cilostazol was superior to aspirin or clopidogrel for the prevention of recurrent stroke and vascular events in a subgroup analysis of intracranial arterial stenosis in the Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com), a randomized controlled trial.We conducted another subgroup analysis to investigate the benefit of DAPT with cilostazol in patients with extracranial arterial stenosis (ECAS) and those without arterial stenosis.We compared the risk of recurrent ischemic stroke, vascular events, and major bleeding between DAPT with cilostazol plus aspirin or clopidogrel and aspirin or clopidogrel alone in patients with ischemic stroke between 8 and 180 days before starting trial treatment and ECAS or without arterial stenosis.The median follow-up period was 1.4 years. The risk of recurrent ischemic stroke (hazard ratio (HR): 1.04, 95% confidence interval (CI): 0.42-2.57) and vascular events (HR: 0.97, 95% CI: 0.42-2.24) did not differ between the two groups for the 253 patients with ECAS, whereas they were lower (HR: 0.36, 95% CI: 0.18-0.74 and HR: 0.47, 95% CI: 0.26-0.85, respectively) in the DAPT group for the 944 patients without arterial stenosis. The risk of major bleeding did not differ between the groups in patients with ECAS (HR: 0.58, 95% CI: 0.05-6.39) or without arterial stenosis (HR: 0.79, 95% CI: 0.27-2.26).DAPT with cilostazol might be beneficial for prevention of recurrent stroke and vascular events in patients without arterial stenosis but not in those with ECAS.We will make the deidentified participant data from this research available to the scientific community with as few restrictions as feasible, while retaining exclusive use until the publication of major output." @default.
• W4283659664 created "2022-06-29" @default.
• W4283659664 creator A5018515174 @default.
• W4283659664 creator A5025141510 @default.
• W4283659664 creator A5025322668 @default.
• W4283659664 creator A5041888985 @default.
• W4283659664 creator A5042534277 @default.
• W4283659664 creator A5055247023 @default.
• W4283659664 creator A5056591092 @default.
• W4283659664 creator A5058879462 @default.
• W4283659664 creator A5081487146 @default.
• W4283659664 date "2022-07-21" @default.
• W4283659664 modified "2023-09-27" @default.
• W4283659664 title "Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial" @default.
• W4283659664 cites W1596397105 @default.
• W4283659664 cites W1996403145 @default.
• W4283659664 cites W2011060894 @default.
• W4283659664 cites W2011192430 @default.
• W4283659664 cites W2015328776 @default.
• W4283659664 cites W2016341115 @default.
• W4283659664 cites W2030673658 @default.
• W4283659664 cites W2081615170 @default.
• W4283659664 cites W2099395511 @default.
• W4283659664 cites W2120544643 @default.
• W4283659664 cites W2124071737 @default.
• W4283659664 cites W2126473393 @default.
• W4283659664 cites W2144194629 @default.
• W4283659664 cites W2397867274 @default.
• W4283659664 cites W2804221421 @default.
• W4283659664 cites W2804570339 @default.
• W4283659664 cites W2889507322 @default.
• W4283659664 cites W2945075257 @default.
• W4283659664 cites W3012021885 @default.
• W4283659664 cites W3039038417 @default.
• W4283659664 cites W3112268408 @default.
• W4283659664 cites W3165856983 @default.
• W4283659664 cites W3202741686 @default.
• W4283659664 cites W3205497827 @default.
• W4283659664 cites W4220677707 @default.
• W4283659664 cites W4297704090 @default.
• W4283659664 doi "https://doi.org/10.1177/17474930221112343" @default.
• W4283659664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35762581" @default.
• W4283659664 hasPublicationYear "2022" @default.
• W4283659664 type Work @default.
• W4283659664 citedByCount "1" @default.
• W4283659664 countsByYear W42836596642023 @default.
• W4283659664 crossrefType "journal-article" @default.
• W4283659664 hasAuthorship W4283659664A5018515174 @default.
• W4283659664 hasAuthorship W4283659664A5025141510 @default.
• W4283659664 hasAuthorship W4283659664A5025322668 @default.
• W4283659664 hasAuthorship W4283659664A5041888985 @default.
• W4283659664 hasAuthorship W4283659664A5042534277 @default.
• W4283659664 hasAuthorship W4283659664A5055247023 @default.
• W4283659664 hasAuthorship W4283659664A5056591092 @default.
• W4283659664 hasAuthorship W4283659664A5058879462 @default.
• W4283659664 hasAuthorship W4283659664A5081487146 @default.
• W4283659664 hasConcept C126322002 @default.
• W4283659664 hasConcept C127413603 @default.
• W4283659664 hasConcept C164705383 @default.
• W4283659664 hasConcept C168563851 @default.
• W4283659664 hasConcept C187960798 @default.
• W4283659664 hasConcept C207103383 @default.
• W4283659664 hasConcept C2777628954 @default.
• W4283659664 hasConcept C2777849778 @default.
• W4283659664 hasConcept C2778905298 @default.
• W4283659664 hasConcept C2779820409 @default.
• W4283659664 hasConcept C2780007028 @default.
• W4283659664 hasConcept C2780645631 @default.
• W4283659664 hasConcept C42219234 @default.
• W4283659664 hasConcept C44249647 @default.
• W4283659664 hasConcept C71924100 @default.
• W4283659664 hasConcept C78519656 @default.
• W4283659664 hasConceptScore W4283659664C126322002 @default.
• W4283659664 hasConceptScore W4283659664C127413603 @default.
• W4283659664 hasConceptScore W4283659664C164705383 @default.
• W4283659664 hasConceptScore W4283659664C168563851 @default.
• W4283659664 hasConceptScore W4283659664C187960798 @default.
• W4283659664 hasConceptScore W4283659664C207103383 @default.
• W4283659664 hasConceptScore W4283659664C2777628954 @default.
• W4283659664 hasConceptScore W4283659664C2777849778 @default.
• W4283659664 hasConceptScore W4283659664C2778905298 @default.
• W4283659664 hasConceptScore W4283659664C2779820409 @default.
• W4283659664 hasConceptScore W4283659664C2780007028 @default.
• W4283659664 hasConceptScore W4283659664C2780645631 @default.
• W4283659664 hasConceptScore W4283659664C42219234 @default.
• W4283659664 hasConceptScore W4283659664C44249647 @default.
• W4283659664 hasConceptScore W4283659664C71924100 @default.
• W4283659664 hasConceptScore W4283659664C78519656 @default.
• W4283659664 hasFunder F4320311405 @default.
• W4283659664 hasFunder F4320324177 @default.
• W4283659664 hasIssue "4" @default.
• W4283659664 hasLocation W42836596641 @default.
• W4283659664 hasLocation W42836596642 @default.
• W4283659664 hasOpenAccess W4283659664 @default.
• W4283659664 hasPrimaryLocation W42836596641 @default.
• W4283659664 hasRelatedWork W1504872639 @default.
• W4283659664 hasRelatedWork W2034438272 @default.
• W4283659664 hasRelatedWork W2047171142 @default.

• next